Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Government of Canada was posted on September 24, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

PR14792_HT282-246471 3D Biopinter

Closed
WS4759714585Canada

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Government of Canada → Department of Public Works and Government ServicesView Agency

NAICS

N/A

Place of Performance

*National Capital Region (NCR), CAN

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyGovernment of Canada → Department of Public Works and Government Services
Contacts1 person available
OfficeN/A
Organization / Agency
Government of Canada → Department of Public Works and Government Services
View Agency Profile
Office AddressN/A
Contacts
Wijaya Putri Yessica Karnali (SPAC/PSPC) (elle-la / she-herPoint of Contact

Full Description

Show more
AMENDMENT TO CLOSING TIME: Please disregard the Ariba Discovery posting response deadline closing time and CanadaBuys posting closing time. All required supporting documentation and bid submission must be submitted by 26 September 2024 at 14:00 EDT. All bids submitted after 14:00 EDT will result in the bid being declared non-responsive. The Mechanistic Studies Division (MSD) of Health Canada has a requirement for a 3D Bioprinter. The 3D bioprinter facilitates the creation of tissues and organs in vitro by blending cells, growth factors, and biomaterials in proportions that mimic physiological conditions. Its digitalized printing capabilities ensure high reproducibility.